Poulvac® Ovoline CVI+HVT
DESCRIPTION
Poulvac® Ovoline CVI+HVT (Rispens-HVT) is a bivalent live virus vaccine for the immunization of chickens against Marek’s disease.
COMPOSITION
Live Marek’s disease virus, serotypes 1 and 3.
INDICATION
Poulvac® Ovoline CVI+HVT (Rispens-HVT) is recommended for the subcutaneous vaccination of healthy 1-day-old chicks or the in ovo vaccination of 18- to 19-day-old embryonated chicken eggs against Marek’s disease.
VACCINATION PROGRAM
Vaccinate healthy 1-day-old chicks subcutaneously.
Vaccinate using the in ovo route of vaccination in 18- to 19-day-old healthy embryonated chicken eggs only.
Dosage: 0.2 mL per chick when given subcutaneously. 0.05 mL per embryonated chicken egg when given in ovo.
METHOD OF ADMINISTRATION
Subcutaneously: For 1-day-old chicks
In ovo injection: For 18- to 19-day-old embryonated chicken eggs
See the product insert for detailed instructions for vaccine administration.
PRESENTATION
Poulvac® Ovoline CVI+HVT is packed in glass ampoules, which are held in canes of 2mL (1,000 or 2,000 doses). Diluent of this vaccine is presented in plastic bottles containing 200ml, 400mL, 800mL, 1200mL and 1600mL. Not all pack sizes are available.
5 x 1,000 doses
5 x 2,000 doses
STORAGE
Store vaccine in liquid nitrogen.
Store diluent at not over 27°C.